These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
621 related items for PubMed ID: 21913948
1. Differences in genotype and allele frequency distributions of polymorphic drug metabolizing enzymes CYP2C19 and CYP2D6 in mainland Chinese Mongolian, Hui and Han populations. Yin SJ, Ni YB, Wang SM, Wang X, Lou YQ, Zhang GL. J Clin Pharm Ther; 2012 Jun; 37(3):364-9. PubMed ID: 21913948 [Abstract] [Full Text] [Related]
2. Allele and genotype frequencies of CYP3A4, CYP2C19, and CYP2D6 in Han, Uighur, Hui, and Mongolian Chinese populations. Zuo LJ, Guo T, Xia DY, Jia LH. Genet Test Mol Biomarkers; 2012 Feb; 16(2):102-8. PubMed ID: 22224559 [Abstract] [Full Text] [Related]
6. Functional allele and genotype frequencies of CYP1A2, CYP2B6 and iNOS among mainland Chinese Tibetan, Mongolian, Uygur and Han populations. Qi GZ, Zhang ZY, Wang X, Yin SJ, Lou YQ, Zhang GL. J Clin Pharm Ther; 2016 Feb; 41(1):84-91. PubMed ID: 26763760 [Abstract] [Full Text] [Related]
7. CYP2C8 polymorphism frequencies among Han, Uighur, Hui, and Mongolian Chinese populations. Wu X, Zuo J, Guo T, Yuan L. Genet Test Mol Biomarkers; 2013 Feb; 17(2):104-8. PubMed ID: 23336573 [Abstract] [Full Text] [Related]
8. Allele and genotype frequencies of polymorphic cytochromes P4502D6, 2C19 and 2E1 in aborigines from western Australia. Griese EU, Ilett KF, Kitteringham NR, Eichelbaum M, Powell H, Spargo RM, LeSouef PN, Musk AW, Minchin RF. Pharmacogenetics; 2001 Feb; 11(1):69-76. PubMed ID: 11207032 [Abstract] [Full Text] [Related]
9. Polymorphisms of drug-metabolizing enzymes CYP2C9, CYP2C19, CYP2D6, CYP1A1, NAT2 and of P-glycoprotein in a Russian population. Gaikovitch EA, Cascorbi I, Mrozikiewicz PM, Brockmöller J, Frötschl R, Köpke K, Gerloff T, Chernov JN, Roots I. Eur J Clin Pharmacol; 2003 Aug; 59(4):303-12. PubMed ID: 12879168 [Abstract] [Full Text] [Related]
10. Distribution of CYP2C19, ABCB1 and PON1 polymorphisms in Chinese Han, Hui, Uygur and Kazak patients with coronary atherosclerotic heart disease. Ma L, Yuan Y, Li J, Yu C, Zhao J. Int J Immunogenet; 2020 Dec; 47(6):539-545. PubMed ID: 32862511 [Abstract] [Full Text] [Related]
17. Pilot study for the characterization of pharmacogenetically relevant CYP2D6, CYP2C19 and ABCB1 gene polymorphisms in the Hungarian population. Rideg O, Háber A, Botz L, Szücs F, Várnai R, Miseta A, Kovács GL. Cell Biochem Funct; 2011 Oct; 29(7):562-8. PubMed ID: 21826689 [Abstract] [Full Text] [Related]
19. Geographical/interracial differences in polymorphic drug oxidation. Current state of knowledge of cytochromes P450 (CYP) 2D6 and 2C19. Bertilsson L. Clin Pharmacokinet; 1995 Sep; 29(3):192-209. PubMed ID: 8521680 [Abstract] [Full Text] [Related]
20. Genetic and epigenetic polymorphisms of eNOS and CYP2D6 in mainland Chinese Tibetan, Mongolian, Uygur, and Han populations. Qi G, Yin S, Zhang G, Wang X. Pharmacogenomics J; 2020 Feb; 20(1):114-125. PubMed ID: 31616043 [Abstract] [Full Text] [Related] Page: [Next] [New Search]